Share

Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay

Jim Cramer sits down with Amgen Chairman and CEO Bob Bradway to hear about the company's recent price cut for one of its key drugs.
08:36
Mon, Jan 7 20191:11 PM EST